Analysis of CVRx, Inc. (CVRX)
CVRx, Inc. is currently showing some interesting technical indicators based on the provided data.
1. The Relative Strength Index (RSI) is quite high at 83.10913, indicating that the stock may be overbought and potentially due for a correction.
2. The Moving Average Convergence Divergence (MACD) indicator is negative at -0.21218, with the MACD line below the signal line. This suggests a bearish trend in the short term.
3. The stock's price has been fluctuating recently, with the price closing at 24.37000. The stock has been trading below its Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA).
Overall, based on the technical indicators, CVRx, Inc. may be facing some short-term bearish pressure. Traders and investors should closely monitor the stock's price movements and key support levels for potential trading opportunities.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuations metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong cash flow with operating cash flow TTM of $110.56 billion and levered free cash flow TTM of $84.73 billion. The balance sheet shows a total cash MRQ of $67.15 billion, total debt MRQ of $104.59 billion, and a current ratio MRQ of 1.037. The profit margin is 26.31%, with a fiscal year ending on September 30, 2023. The income statement reveals EBITDA of $131.39 billion, revenue TTM of $381.62 billion, and a diluted EPS TTM of 6.43.
Moving on to stock statistics, the company has a short ratio of 1.53, float shares of 15.31 billion, and shares short of 99.29 million. The stock has outstanding shares of 15.33 billion, with 5.22% held by insiders and 57.59% held by institutions.
Valuation metrics show a PEG ratio of 26.32, forward PE of 26.32, and trailing PE of 29.59. The enterprise value is $2.95 trillion, with a price to book MRQ of 39.34 and price to sales TTM of 7.65.
The stock price summary includes a beta of 1.264, 50-day moving average of $176.26, and 200-day moving average of $181.04. The 52-week range is between $164.08 and $199.62, with a 52-week change of 6.85%.
Lastly, dividends and splits information shows a payout ratio of 14.93%, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split factor. The forward annual dividend rate is $1, with a 5-year average dividend yield of 0.73% and a forward annual dividend yield of 0.53%. The trailing annual dividend rate is $0.97, with a trailing annual dividend yield of 0.51%.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:
- 2020: $274,515,000,000
- 2021: $365,817,000,000
- 2022: $394,328,000,000
- 2023: $383,285,000,000
From these numbers, we can observe that the company experienced a steady increase in revenue from 2020 to 2022, reaching its peak in 2022. However, there was a slight decrease in revenue in 2023 compared to 2022. This trend indicates a period of growth followed by a slight decline in revenue for the company.
Balance Sheet
These are balance sheets. Here are the conclusions:
1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and receivables, with a significant portion in cash equivalents and short-term investments.
3. Non-current assets consist mainly of investments and advances, along with machinery, furniture, and equipment.
4. Total liabilities have also been increasing, but at a slower pace compared to assets.
5. Shareholders' equity has shown a positive trend, indicating a healthy financial position.
6. The company has been managing its short-term and long-term debts effectively.
7. Accumulated depreciation has been significant, affecting the value of non-current assets.
8. The company has been investing in leases, land, and improvements over the years.
9. There is a consistent provision for risks and charges in the liabilities section.
10. Overall, the company's financial health seems stable and improving over the years.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with some fluctuations in key financial metrics over the years.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, with a low estimate of $5.95 and a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:
1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are generally optimistic about the company's future sales performance, with moderate to healthy growth expected in both the quarterly and annual periods. The increasing number of analysts providing estimates for the future periods also indicates a growing interest in the company's financial outlook.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:
1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the near term compared to the past 5 years. However, the company is still projected to maintain a healthy growth rate over the next year and the next 5 years according to analyst consensus.
Price target
Based on the analysts' forecast, the future price of the security is expected to range between $164 (low) and $250 (high), with a median estimate of $200 and an average estimate of $202.26. The current price of the security is $191.57.MACD of CVRX